In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Decisions Expected: October 2025 Prime Therapeutics Portal FDA to weigh easing limits on unproven peptides promoted by RFK Jr. FDA to weigh easing limits on unproven peptides A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read BPC 157: What you need to know before you try it You are hearing more about BPC 157. Patients ask about it daily. Here are the most common questions answered. What is BPC 157? BPC 157